Pentoxi-Mepha 400, Retardtabletten

7680493240140 CH-49324 C04AD03 02.04.5.
Pentoxi-Mepha 400, Retardtabletten
Pentoxi-Mepha 400, Retardtabletten
Pentoxi-Mepha 400, Retardtabletten
1 / 3
google

Details

Product number
4932401
CPT
-
Packaging group
20
Unit
Tablette(n)
Composition
pentoxifyllinum 400 mg, povidonum K 90, ammonio methacrylatis copolymerum B, cellulosum microcristallinum, talcum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, E 171, macrogolum 6000, acidi ethacrylici et methylis methacrylatis polymerisatum, pro compresso.

Articles (1)

Pentoxi-Mepha 400, Retardtabletten
Tabletten
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/04/2023
Patient information leaflet
Français
14/04/2023
Patient information leaflet
Italien
14/04/2023
Professional SmPC
Allemand
14/04/2023
Professional SmPC
Français
14/04/2023
Professional SmPC
Italien
14/04/2023

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
49324
Drug name
Pentoxi-Mepha 400, Retardtabletten
Galenic form
RETT
ATC Code
C04AD03
Authorization status
Z
Dispensation category
B
First authorization
30/06/1988
Authorization expiration date
31/12/2025
IT number
02.04.5.
Domain
Human medicine
Field of application
Durchblutungsstörungen

Packaging details

Description (FR)
PENTOXI Mepha cpr ret 400 mg 20 pce
Description (DE)
PENTOXI Mepha Ret Tabl 400 mg 20 Stk
Narcotic (BTM)
No

Other packaging sizes